This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Fred Hutchinson Cancer Center. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Grant D. Trobridge: Innovator in Gene Therapy
Introduction
Grant D. Trobridge is a notable inventor based in Lake Forest Park, WA (US). He has made significant contributions to the field of gene therapy through his innovative work. His research focuses on developing advanced retroviral vectors that can enhance gene delivery methods.
Latest Patents
Grant D. Trobridge holds a patent for "Cocal vesiculovirus envelope pseudotyped retroviral vectors." This invention provides vectors that exhibit high titers, broad species and cell-type tropism, and improved serum stability. The disclosed vectors are particularly suitable for gene therapy applications, enabling both ex vivo and in vivo delivery of genes of interest to a wide variety of target cells.
Career Highlights
Trobridge is affiliated with the Fred Hutchinson Cancer Center, where he continues to advance his research in gene therapy. His work has the potential to impact various medical fields, particularly in treating genetic disorders and enhancing therapeutic strategies.
Collaborations
One of his notable collaborators is Hans-Peter Kiem, with whom he has worked on various projects related to gene therapy and retroviral vectors.
Conclusion
Grant D. Trobridge's contributions to the field of gene therapy through his innovative patents and research at the Fred Hutchinson Cancer Center highlight his role as a leading inventor in this critical area of medicine. His work continues to pave the way for advancements in gene delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile